Osetomics LLC


Osetomics focuses on developing diagnostic and prognostic tools aimed at treating acute musculoskeletal injuries, chronic orthopedic pathologies, and complications related to bone implants. The company is part of the PCI Ventures initiative, which supports the commercialization of innovative technologies from the University of Pennsylvania.

Industries

biopharma
biotechnology
health-care
life-science

Nr. of Employees

Very Large (1000+)

Osetomics LLC

Philadelphia, Pennsylvania, United States, North America


Products

Diagnostic and prognostic toolset for musculoskeletal conditions

A program to develop diagnostic assays and prognostic methods aimed at assessing acute musculoskeletal injuries, chronic orthopedic pathologies, and bone implant complications.


Services

Development of diagnostic and prognostic tools for musculoskeletal medicine

Research and product development to produce diagnostic assays and prognostic methods for acute musculoskeletal injuries, chronic orthopedic conditions, and implant-related complications.

Access to university venture support services

Programmatic support through a university venture group offering company formation assistance, legal templates, vendor relationships, mentorship, executive recruitment introductions, internship connections, coaching, office hours, IP strategy support, and grant-submission assistance to early-stage ventures.

Expertise Areas

  • Orthopedic and musculoskeletal diagnostics
  • Prognostic model development and predictive analytics
  • Clinical validation and diagnostic assay development
  • Startup formation and commercialization support for life-science ventures

Key Technologies

  • Diagnostic assay development
  • Predictive analytics for prognosis
  • Clinical validation workflows

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.